Executive Change: Cleveland Diagnostics Inc. Appoints Valerie Dixon as Chief Financial Officer

Cleveland, OH – Cleveland Diagnostics Inc. has announced the appointment of Valerie Dixon as Chief Financial Officer. About Cleveland Diagnostics Inc.: Cleveland Diagnostics Inc. is a precision oncology company focused on improving the early detection of cancer through novel blood-based diagnostics. Its website says the company offers simple blood tests designed to help identify the presence or absence of disease and to detect cancer more accurately. The companys proprietary IsoClear platform measures changes in protein structure to uncover underlying cancer biology, and it is built to support easy-to-run tests in the clinical lab setting. Cleveland Diagnostics highlights its IsoPSA test as a flagship product, aimed at providing actionable information for assessing the likelihood of high-grade prostate cancer. The company presents itself as a commercial-stage innovator in cancer diagnostics with a mission to change how cancer is detected.

For more information visit: https://www.clevelanddx.com/

Cleveland Diagnostics Inc.
3615 Superior Avenue
Cleveland, OH 44114
Phone: 216-432-2700
LinkedIn: https://www.linkedin.com/company/cleveland-diagnostics-inc.

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved